International journal of pharmaceuticsHumansLiver CirrhosisNanomedicineAnimalsNanoparticle Drug Delivery System
Advanced strategies based on nanomedicine for Liver fibrosis treatment.
Lu Zhang, Tingting Liu, Huan Shen, Boheng Liu, Yun Mei, Yang Liu, Shuo Chen, Xingcong Ma, Chenyang He, Tinghua Hu, Bin Li, Gang Cao, Shuo Yu
Published: 202610.1016/j.ijpharm.2025.126437
Abstract
Liver fibrosis (LF) is a significant pathological manifestation in various types of chronic liver diseases andis associated withsubstantial global morbidity and mortality. While liver transplantation remains a treatment option,existing clinical pharm…
Preview only. Read the full abstract at the source